Real-world efficacy and safety of dupilumab for atopic dermatitis in a Hispanic population: A single-center retrospective cohort study

被引：0
作者：
Santiago-Vazquez, Marely [1 ]
Pelet, Natalia [2 ]
Cuesta, Jose M. [3 ]
Michelen, Eduardo [2 ]
Ramos, Alvaro J. [1 ]
Martin, Rafael F. [1 ]
机构：
[1] Univ Puerto Rico, Dept Dermatol, San Juan, PR USA
[2] Univ Puerto Rico, Transit Year Program, San Juan, PR USA
[3] VA Caribbean Healthcare Syst, San Juan, PR USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34201
引用
收藏
页码：AB199 / AB199
页数：1
相关论文
共 50 条
[21]   Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study [J].
Uchida, H. ;
Kamata, M. ;
Mizukawa, I. ;
Watanabe, A. ;
Agematsu, A. ;
Nagata, M. ;
Fukaya, S. ;
Hayashi, K. ;
Fukuyasu, A. ;
Tanaka, T. ;
Ishikawa, T. ;
Ohnishi, T. ;
Tada, Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (05) :1083-1085
[22]   Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study [J].
Vignoli, Carlo Alberto .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[23]   Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study [J].
Georgakopoulos, Jorge R. ;
Felfeli, Tina ;
Drucker, Aaron M. ;
Jo, Christine E. ;
Piguet, Vincent ;
Yeung, Jensen .
JAAD INTERNATIONAL, 2021, 4 :67-69
[24]   Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study [J].
Huang, Xiaolu ;
Lin, Fuan ;
Chen, Hongpu .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (09) :902-909
[25]   Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study [J].
Sood, Siddhartha ;
Georgakopoulos, Jorge R. ;
Maliyar, Khalad ;
Sachdeva, Muskaan ;
Mufti, Asfandyar ;
Yeung, Jensen .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) :96-97
[26]   Real-world effectiveness and drug survival of dupilumab: A single-center retrospective analysis [J].
Brazil, Molly ;
Topham, Christina ;
Simpson, Eric .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB123-AB123
[27]   Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study [J].
Jo, Christine E. ;
Georgakopoulos, Jorge R. ;
Ladda, Matthew ;
Ighani, Arvin ;
Mufti, Asfandyar ;
Drucker, Aaron M. ;
Piguet, Vincent ;
Yeung, Jensen .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (05) :468-473
[28]   Dupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey [J].
Salman, Andac ;
Aktas, Meryem ;
Ozkurkcu, Esra ;
Sarac, Gonca ;
Taskapan, Oktay ;
Ergun, Tulin .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB144-AB144
[29]   Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China [J].
Wang, Yuyi ;
Jia, Ruiling ;
Hu, Qin ;
Tao, Xiao ;
He, Qi ;
Luo, Guangying ;
Xiong, Qiong ;
Zhang, Zhongyu ;
Xiao, Yujuan ;
Liu, Yi .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[30]   Real-world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single-centre, prospective, open-label study [J].
Gu, C. ;
Wu, Y. ;
Luo, Y. ;
Wang, S. ;
Yin, H. ;
Gao, Y. ;
Wang, C. ;
Yao, X. ;
Li, W. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) :1064-1073
12345